Literature DB >> 30482698

Changing epidemiology of non-albicans candidemia in Korea.

Jae-Hoon Ko1, Dong Sik Jung2, Ji Yeon Lee3, Hyun Ah Kim3, Seong Yeol Ryu3, Sook-In Jung4, Eun-Jeong Joo5, Shinhye Cheon6, Yeon-Sook Kim6, Shin-Woo Kim7, Sun Young Cho1, Cheol-In Kang1, Doo Ryeon Chung1, Nam Yong Lee8, Kyong Ran Peck9.   

Abstract

An epidemiologic surveillance of non-albicans candidemia for a 6-year period was conducted in Korea. Compared to the published epidemiologic data for the previous 6 years, an increase of C. glabrata (from 21.3% to 28.5%) and a decrease of C. parapsilosis (from 36.5% to 24.7%) were noticed. During the study period, C. tropicalis (36.4%) was most frequently isolated non-albicans Candida, followed by C. glabrata (28.5%), C. parapsilosis (24.7%), and C. krusei (2.6%). Replacement of primary amphotericin B treatment with echinocandins (P < 0.001) eliminated amphotericin B resistance (from 7.8% in 2011 to 0% in 2014).
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Antifungal resistance; Candida glabrata; Candida parapsilosis; Epidemiology; non-albicans Candida

Mesh:

Substances:

Year:  2018        PMID: 30482698     DOI: 10.1016/j.jiac.2018.09.016

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  8 in total

1.  Intrinsically High Resistance of Candida glabrata to Hydrogen Peroxide and Its Reversal in a Fluconazole-Resistant Mutant.

Authors:  Tom Edlind; Santosh Katiyar
Journal:  Antimicrob Agents Chemother       Date:  2022-08-02       Impact factor: 5.938

Review 2.  Mechanisms of Candida Resistance to Antimycotics and Promising Ways to Overcome It: The Role of Probiotics.

Authors:  Konstantin A Demin; Aleksandr G Refeld; Anna A Bogdanova; Evgenya V Prazdnova; Igor V Popov; Olga Yu Kutsevalova; Alexey M Ermakov; Anzhelica B Bren; Dmitry V Rudoy; Vladimir A Chistyakov; Richard Weeks; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2021-03-18       Impact factor: 4.609

3.  Roles of Elm1 in antifungal susceptibility and virulence in Candida glabrata.

Authors:  Yuya Ito; Taiga Miyazaki; Yutaka Tanaka; Takashi Suematsu; Hironobu Nakayama; Akihiro Morita; Tatsuro Hirayama; Masato Tashiro; Takahiro Takazono; Tomomi Saijo; Shintaro Shimamura; Kazuko Yamamoto; Yoshifumi Imamura; Koichi Izumikawa; Katsunori Yanagihara; Shigeru Kohno; Hiroshi Mukae
Journal:  Sci Rep       Date:  2020-06-17       Impact factor: 4.379

Review 4.  Current Aspects in the Biology, Pathogeny, and Treatment of Candida krusei, a Neglected Fungal Pathogen.

Authors:  Manuela Gómez-Gaviria; Héctor M Mora-Montes
Journal:  Infect Drug Resist       Date:  2020-06-10       Impact factor: 4.003

Review 5.  Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium.

Authors:  Amir Arastehfar; Toni Gabaldón; Rocio Garcia-Rubio; Jeffrey D Jenks; Martin Hoenigl; Helmut J F Salzer; Macit Ilkit; Cornelia Lass-Flörl; David S Perlin
Journal:  Antibiotics (Basel)       Date:  2020-12-08

6.  Comparison of Six Antifungal Susceptibilities of 11 Candida Species Using the VITEK2 AST-YS08 Card and Broth Microdilution Method.

Authors:  Hyeyoung Lee; Seong Hyouk Choi; Junsang Oh; Jehyun Koo; Hyun Ji Lee; Sung-Il Cho; Jeong Hwan Shin; Hae Kyung Lee; Soo-Young Kim; Chae Hoon Lee; Young Ree Kim; Yong-Hak Sohn; Woo Jin Kim; Sook Won Ryu; Gi-Ho Sung; Jayoung Kim
Journal:  Microbiol Spectr       Date:  2022-04-06

7.  A multicenter retrospective analysis of the antifungal susceptibility patterns of Candida species and the predictive factors of mortality in South Korean patients with candidemia.

Authors:  In Young Jung; Su Jin Jeong; Young Keun Kim; Hyo Youl Kim; Young Goo Song; June Myung Kim; Jun Yong Choi
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

8.  Fluconazole-Resistant Candida glabrata Bloodstream Isolates, South Korea, 2008-2018.

Authors:  Eun Jeong Won; Min Ji Choi; Mi-Na Kim; Dongeun Yong; Wee Gyo Lee; Young Uh; Taek Soo Kim; Seung Ah Byeon; Seung Yeob Lee; Soo Hyun Kim; Jong Hee Shin
Journal:  Emerg Infect Dis       Date:  2021-03       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.